UCP Bioscience Inc
FDA inspection history across 2 sites, 2017 to 2024
- 2
- Form 483s
Every document, by year
- Form 483
2017: one Form 483; 2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2017One Form 483, at San Jose, California.
- 2017The longest 483 on file: 4 observations over 5 pages at San Jose, California.
- 2024One Form 483, at Milpitas, California.
Cited most
Across all UCP Bioscience observations on file
- 21 CFR 820.30Design controls3
- 21 CFR 501
- 21 CFR 8201
- 21 CFR 50.27Documentation of informed consent1
- 21 CFR 803.17What are the requirements for developing, maintaining, and implementing written MDR procedures that apply to me?1
The complete UCP Bioscience file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Milpitas, California
One Form 483 · 2024 · 3 observations
Latest: Form 483, Nov 18, 2024 →San Jose, California
One Form 483 · 2017 · 4 observations
Latest: Form 483, Mar 17, 2017 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-11-18 | 483 Form 483 | Milpitas, California | 3 | $99 |
| 2017-03-17 | 483 Form 483 | San Jose, California | 4 | $99 |
Investigators on these documents
Brittany D. McCracken (1)Mary R. Hole (1)Sandra S. Saniga (1)
FEI number 3004987297 · most recent document Nov 18, 2024
About UCP Bioscience Inc
How many FDA Form 483s has UCP Bioscience Inc received?
FDA Intel has 2 Form 483s on file for UCP Bioscience Inc; the most recent is dated Nov 18, 2024.
When was UCP Bioscience Inc last inspected by FDA?
The most recent FDA inspection document on file for UCP Bioscience Inc is a Form 483 dated Nov 18, 2024, for the site in Milpitas, California.
What did FDA cite at UCP Bioscience Inc?
The regulations cited most in the observations on file for UCP Bioscience Inc are 21 CFR 820.30 (Design controls), 3 times; 21 CFR 50, 1 time; 21 CFR 820, 1 time.